@article{MTMT:34543527, title = {GYAKORI TüNETEK RITKA OKAI: MYELOMA MULTIPLEX SZÖVŐDMÉNYEKÉNT KIALAKULT KRÓNIKUS HASMENÉS ÉS SZEKUNDER ADDISON-KÓR}, url = {https://m2.mtmt.hu/api/publication/34543527}, author = {Kormányos, Eszter Sára and Illés, Dóra and Kui, Balázs and Lemes, K and Tajti, M and Czakó, László}, journal-iso = {MBA}, journal = {MAGYAR BELORVOSI ARCHIVUM}, volume = {76}, unique-id = {34543527}, issn = {0133-5464}, year = {2023}, pages = {317-318}, orcid-numbers = {Czakó, László/0000-0002-6331-0802} } @article{MTMT:34162226, title = {Multidisciplinary management of acute cholecystitis during the COVID-19 pandemic}, url = {https://m2.mtmt.hu/api/publication/34162226}, author = {Tóth, Illés János and Ábrahám, Szabolcs and Karamya, Zain Alabedeen and Benkő, Ria and Matuz, Mária and Nagy, András and Váczi, Dániel and Négyessy, András and Czakó, Bálint and Illés, Dóra and Tajti, Máté and Ivány, Emese and Lázár, György ifj and Czakó, László}, doi = {10.1038/s41598-023-43555-3}, journal-iso = {SCI REP}, journal = {SCIENTIFIC REPORTS}, volume = {13}, unique-id = {34162226}, issn = {2045-2322}, abstract = {The coronavirus disease 2019 pandemic had a major impact on most medical services. Our aim was to assess the outcome of acute cholecystitis during the nationwide lockdown period. All patients admitted to our emergency department for AC were analysed. Patient characteristics, performance status, AC severity, treatment modality and outcome of AC were assessed during the lockdown period (Period II: 1 April 2020–30 November 2021) and compared to a historical control period (Period I: 1 May 2017–31 December 2018). AC admissions increased by 72.8% in Period II. Patients were younger (70 vs. 74 years, p = 0.017) and greater in number in the CCI 1 group (20.4% vs. 11.2%, p = 0.043) in Period II. The unplanned readmission rate (6.3 vs. 0%, p = 0.004) and the gallbladder perforation (GP) rate was higher (18.0 vs. 7.3%, p = 0.006) in Period II. Percutaneous transhepatic gallbladder drainage (PTGBD) was more frequent (24.1 vs. 12.8%, p = 0.012) in Period II. In addition to a drop in patient age and CCI, a significant rise in the prevalence of acute cholecystitis, GP and unplanned readmissions was observed during the nationwide lockdown due to the COVID-19 pandemic. PTGBD was more frequent during this period, whereas successful conservative treatment was less frequent.}, year = {2023}, eissn = {2045-2322}, orcid-numbers = {Tóth, Illés János/0000-0001-9549-2199; Ábrahám, Szabolcs/0000-0002-2191-1714; Benkő, Ria/0000-0002-8009-8962; Matuz, Mária/0000-0002-7877-2399; Váczi, Dániel/0000-0001-6555-2664; Lázár, György ifj/0000-0001-7155-2978; Czakó, László/0000-0002-6331-0802} } @article{MTMT:34072590, title = {Invalidity of Tokyo guidelines in acute biliary pancreatitis : A multicenter cohort analysis of 944 pancreatitis cases}, url = {https://m2.mtmt.hu/api/publication/34072590}, author = {Juhász, Márk Félix and Tóháti, Rebeka and Jászai, Viktória Adrienn and Molnár, Regina and Borbásné Farkas, Kornélia and Czakó, László and Vincze, Áron and Erőss, Bálint Mihály and Szentesi, Andrea Ildikó and Izbéki, Ferenc and Papp, Mária and Hegyi, Péter and Párniczky, Andrea}, doi = {10.1002/ueg2.12402}, journal-iso = {UEG JOURNAL}, journal = {UNITED EUROPEAN GASTROENTEROLOGY JOURNAL}, volume = {11}, unique-id = {34072590}, issn = {2050-6406}, abstract = {There is a noteworthy overlap between the clinical picture of biliary acute pancreatitis (AP) and the 2018 Tokyo guidelines currently used for the diagnosis of cholangitis (AC) and cholecystitis (CC). This can lead to significant antibiotic and endoscopic retrograde cholangiopancreatography (ERCP) overuse.We aimed to assess the on-admission prevalence of AC/CC according to the 2018 Tokyo guidelines (TG18) in a cohort of biliary AP patients, and its association with antibiotic use, ERCP and clinically relevant endpoints.We conducted a secondary analysis of the Hungarian Pancreatic Study Group's prospective multicenter registry of 2195 AP cases. We grouped and compared biliary cases (n = 944) based on the on-admission fulfillment of definite AC/CC according to TG18. Aside from antibiotic use, we evaluated mortality, AC/CC/AP severity, ERCP performance and length of hospitalization. We also conducted a literature review discussing each criteria of the TG18 in the context of AP.27.8% of biliary AP cases fulfilled TG18 for both AC and CC, 22.5% for CC only and 20.8% for AC only. Antibiotic use was high (77.4%). About 2/3 of the AC/CC cases were mild, around 10% severe. Mortality was below 1% in mild and moderate AC/CC patients, but considerably higher in severe cases (12.8% and 21.2% in AC and CC). ERCP was performed in 89.3% of AC cases, common bile duct stones were found in 41.1%.Around 70% of biliary AP patients fulfilled the TG18 for AC/CC, associated with a high rate of antibiotic use. Mortality in presumed mild or moderate AC/CC is low. Each of the laboratory and clinical criteria are commonly fulfilled in biliary AP, single imaging findings are also unspecific-AP specific diagnostic criteria are needed, as the prevalence of AC/CC are likely greatly overestimated. Randomized trials testing antibiotic use are also warranted.}, keywords = {MORTALITY; Antibiotic use; cholangitis; endoscopic retrograde cholangiopancreatography; cholecystitis; ERCP; STONES; Biliary acute pancreatitis; 2018 Tokyo guidelines}, year = {2023}, eissn = {2050-6414}, pages = {767-774}, orcid-numbers = {Molnár, Regina/0009-0009-7067-1647; Borbásné Farkas, Kornélia/0000-0002-5349-6527; Czakó, László/0000-0002-6331-0802; Vincze, Áron/0000-0003-2217-7686; Erőss, Bálint Mihály/0000-0003-3658-8427; Szentesi, Andrea Ildikó/0000-0003-2097-6927; Izbéki, Ferenc/0000-0001-7767-4319; Papp, Mária/0000-0003-3662-4010; Hegyi, Péter/0000-0003-0399-7259; Váncsa, Szilárd/0000-0002-9347-8163; Márta, Katalin/0000-0002-2213-4865; Nagy, Rita/0000-0002-2663-4912; Imrei, Marcell/0000-0003-0175-7462; Maurovich-Horvat, Pál/0000-0003-0885-736X; Doros, Attila/0000-0002-6496-9895; Zubek, László/0000-0003-0583-3290; Gál, János/0000-0001-9160-6478} } @article{MTMT:33864451, title = {Detailed characteristics of post-discharge mortality in acute pancreatitis}, url = {https://m2.mtmt.hu/api/publication/33864451}, author = {Turcsiné Czapári, Dóra and Váradi, Alex and Borbásné Farkas, Kornélia and Nyári, Gergely Róbert and Márta, Katalin and Váncsa, Szilárd and Nagy, Rita and Teutsch, Brigitta and Bunduc, Stefania and Erőss, Bálint Mihály and Czakó, László and Vincze, Áron and Izbéki, Ferenc and Papp, Mária and Merkely, Béla Péter and Szentesi, Andrea Ildikó and Hegyi, Péter}, doi = {10.1053/j.gastro.2023.05.028}, journal-iso = {GASTROENTEROLOGY}, journal = {GASTROENTEROLOGY}, volume = {165}, unique-id = {33864451}, issn = {0016-5085}, abstract = {The in-hospital survival of patients suffering from acute pancreatitis (AP) is 95-98%. However, there is growing evidence that patients discharged after AP may be at risk of serious morbidity and mortality. Here, we aimed to investigate the risk, causes, and predictors of the most severe consequence of the post-AP period: mortality.2,613, well-characterized patients from twenty-five centers were collected and followed by the Hungarian Pancreatic Study Group between 2012 and 2021. A general and a hospital-based population was used as the control group.After an AP episode patients have an approximately three-fold higher incidence rate of mortality than the general population (0.0404vs.0.0130 person-years). First-year mortality after discharge was almost double than in-hospital mortality (5.5%vs.3.5%), with 3.0% occurring in the first 90-day period. Age, comorbidities, and severity were the most significant independent risk factors for death following AP. Furthermore, multivariate analysis identified creatinine, glucose, and pleural fluid on admission as independent risk factors associated with post-discharge mortality. In the first 90-day period, cardiac failure and AP-related sepsis were among the main causes of death following discharge, while cancer-related cachexia and non-AP-related infection were the key causes in the later phase.Almost as many patients in our cohort die in the first 90-day period after discharge as during their hospital stay. Evaluation of cardiovascular status, follow-up of local complications, and cachexia-preventing oncological care should be an essential part of post-AP patient care. Future study protocols in AP must include at least a 90-day follow-up period after discharge.}, year = {2023}, eissn = {1528-0012}, pages = {682-695}, orcid-numbers = {Váradi, Alex/0000-0001-8229-6340; Borbásné Farkas, Kornélia/0000-0002-5349-6527; Márta, Katalin/0000-0002-2213-4865; Váncsa, Szilárd/0000-0002-9347-8163; Nagy, Rita/0000-0002-2663-4912; Teutsch, Brigitta/0000-0002-9530-7886; Erőss, Bálint Mihály/0000-0003-3658-8427; Czakó, László/0000-0002-6331-0802; Vincze, Áron/0000-0003-2217-7686; Izbéki, Ferenc/0000-0001-7767-4319; Papp, Mária/0000-0003-3662-4010; Merkely, Béla Péter/0000-0001-6514-0723; Szentesi, Andrea Ildikó/0000-0003-2097-6927; Hegyi, Péter/0000-0003-0399-7259; Imrei, Marcell/0000-0003-0175-7462; Németh, Balázs/0000-0001-5338-7577; Tiszlavicz, László/0000-0003-1134-6587; Oláh, Orsolya/0000-0002-5731-4030; Vitális, Zsuzsanna/0000-0001-8198-5312; Doros, Attila/0000-0002-6496-9895} } @article{MTMT:33842885, title = {Epeút- és epehólyag-gyulladás: diagnosztikus kritériumok és terápia [Cholangitis and cholecystitis: diagnostic criteria and management]}, url = {https://m2.mtmt.hu/api/publication/33842885}, author = {Czakó, László and Gyökeres, Tibor Zoltán and Hritz, István and Madácsy, László and Illés, Dóra and Szepes, Zoltán and Dubravcsik, Zsolt and Péterfi, Zoltán and Nagy, András and Szűcs, Ákos and Vincze, Áron}, doi = {10.1556/650.2023.32770}, journal-iso = {ORV HETIL}, journal = {ORVOSI HETILAP}, volume = {164}, unique-id = {33842885}, issn = {0030-6002}, abstract = {In developed countries, diseases of the gallbladder and the biliary tract count as some of the most frequent gastrointestinal disorders. The inflammation of the gallbladder/biliary tree is a potentially severe, even lethal condition that requires rapid diagnosis and early multidisciplinary approach to be treated. Although the frequency of these diseases is high, the treatment is not unified in Hungary yet. The aim of the evidence-based recommendation is to clarify the diagnostic criteria and severity grading of these diseases and to highlight the indications and rules of proper application of the numerous available therapeutic interventions. The recent guideline is based on the consensus of the Board members of the Endoscopic Section of the Hungarian Gastroenterology Society in contribution with renown experts of surgery, infectology as well as interventional radiology and it counts as a clear and easy applicable guide during the all-day healthcare practice. Our guidelines are based on Tokyo guidelines established on the basis of the consensus reached in the International Consensus Meeting held in Tokyo which were revised in 2013 (TG13) and in 2018 (TG18). Orv Hetil. 2023; 164(20): 770-787.}, keywords = {Cholecystectomy; antimicrobial therapy; Acute cholecystitis; CHOLECYSTECTOMIA; antibiotikus kezelés; biliary drainage; Severity grading; acute cholangitis; akut cholangitis; akut cholecystitis; epeúti drenázs; súlyossági osztályozás}, year = {2023}, eissn = {1788-6120}, pages = {770-787}, orcid-numbers = {Czakó, László/0000-0002-6331-0802; Hritz, István/0000-0002-8763-6006; Szepes, Zoltán/0000-0002-9466-8719; Péterfi, Zoltán/0000-0001-9658-153X; Vincze, Áron/0000-0003-2217-7686} } @article{MTMT:33761635, title = {Metabolic-associated fatty liver disease is associated with acute pancreatitis with more severe course : Post hoc analysis of a prospectively collected international registry}, url = {https://m2.mtmt.hu/api/publication/33761635}, author = {Váncsa, Szilárd and Sipos, Zoltán and Váradi, Alex and Nagy, Rita and Ocskay, Klementina and Juhász, Márk Félix and Márta, Katalin and Teutsch, Brigitta and Mikó, Alexandra and Hegyi, Péter Jenő and Vincze, Áron and Izbéki, Ferenc and Czakó, László and Papp, Mária and Hamvas, József and Varga, Márta and Török, Imola and Mickevicius, Artautas and Erőss, Bálint Mihály and Párniczky, Andrea and Szentesi, Andrea Ildikó and Pár, Gabriella and Hegyi, Péter}, doi = {10.1002/ueg2.12389}, journal-iso = {UEG JOURNAL}, journal = {UNITED EUROPEAN GASTROENTEROLOGY JOURNAL}, volume = {11}, unique-id = {33761635}, issn = {2050-6406}, abstract = {Non-alcoholic fatty liver disease (NAFLD) is a proven risk factor for acute pancreatitis (AP). However, NAFLD has recently been redefined as metabolic-associated fatty liver disease (MAFLD). In this post hoc analysis, we quantified the effect of MAFLD on the outcomes of AP.We identified our patients from the multicentric, prospective International Acute Pancreatitis Registry of the Hungarian Pancreatic Study Group. Next, we compared AP patients with and without MAFLD and the individual components of MAFLD regarding in-hospital mortality and AP severity based on the revised Atlanta classification. Lastly, we calculated odds ratios (ORs) with 95% confidence intervals (CIs) using multivariate logistic regression analysis.MAFLD had a high prevalence in AP, 39% (801/2053). MAFLD increased the odds of moderate-to-severe AP (OR = 1.43, CI: 1.09-1.89). However, the odds of in-hospital mortality (OR = 0.89, CI: 0.42-1.89) and severe AP (OR = 1.70, CI: 0.97-3.01) were not higher in the MAFLD group. Out of the three diagnostic criteria of MAFLD, the highest odds of severe AP was in the group based on metabolic risk abnormalities (OR = 2.68, CI: 1.39-5.09). In addition, the presence of one, two, and three diagnostic criteria dose-dependently increased the odds of moderate-to-severe AP (OR = 1.23, CI: 0.88-1.70, OR = 1.38, CI: 0.93-2.04, and OR = 3.04, CI: 1.63-5.70, respectively) and severe AP (OR = 1.13, CI: 0.54-2.27, OR = 2.08, CI: 0.97-4.35, and OR = 4.76, CI: 1.50-15.4, respectively). Furthermore, in patients with alcohol abuse and aged ≥60 years, the effect of MAFLD became insignificant.MAFLD is associated with AP severity, which varies based on the components of its diagnostic criteria. Furthermore, MAFLD shows a dose-dependent effect on the outcomes of AP.}, keywords = {MORTALITY; Prognosis; metabolic syndrome; SEVERITY; Acute pancreatitis; STEATOSIS; Non-Alcoholic Fatty Liver Disease; NAFLD; MAFLD; Metabolic-associated fatty liver disease}, year = {2023}, eissn = {2050-6414}, pages = {371-382}, orcid-numbers = {Váncsa, Szilárd/0000-0002-9347-8163; Sipos, Zoltán/0000-0001-7845-8116; Váradi, Alex/0000-0001-8229-6340; Nagy, Rita/0000-0002-2663-4912; Ocskay, Klementina/0000-0001-5848-2506; Márta, Katalin/0000-0002-2213-4865; Teutsch, Brigitta/0000-0002-9530-7886; Vincze, Áron/0000-0003-2217-7686; Izbéki, Ferenc/0000-0001-7767-4319; Czakó, László/0000-0002-6331-0802; Papp, Mária/0000-0003-3662-4010; Erőss, Bálint Mihály/0000-0003-3658-8427; Szentesi, Andrea Ildikó/0000-0003-2097-6927; Hegyi, Péter/0000-0003-0399-7259; Imrei, Marcell/0000-0003-0175-7462; Németh, Balázs/0000-0001-5338-7577; Maurovich-Horvat, Pál/0000-0003-0885-736X; Doros, Attila/0000-0002-6496-9895; Zubek, László/0000-0003-0583-3290; Gál, János/0000-0001-9160-6478; Tari, Edina/0000-0002-8540-0614} } @article{MTMT:34013125, title = {Endoscopic papillectomy for ampullary adenoma: are we good enough?}, url = {https://m2.mtmt.hu/api/publication/34013125}, author = {Gieszinger, G. and Tajti, M. and Karamya, Zain Alabedeen and Szepes, Zoltán and Takács, Tamás and Kui, Balázs and Illés, Dóra and Ivány, Emese and Czakó, László}, journal-iso = {CENT EUR J GASTRO HEPATOL}, journal = {CENTRAL EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY / GASZTROENTEROLÓGIAI ÉS HEPATOLÓGIAI SZEMLE}, volume = {8}, unique-id = {34013125}, year = {2022}, eissn = {2415-9107}, pages = {78-78}, orcid-numbers = {Szepes, Zoltán/0000-0002-9466-8719; Czakó, László/0000-0002-6331-0802} } @article{MTMT:32823615, title = {Early prediction of acute necrotizing pancreatitis by artificial intelligence : a prospective cohort-analysis of 2387 cases}, url = {https://m2.mtmt.hu/api/publication/32823615}, author = {Kiss, Szabolcs and Pintér, József and Molontay, Roland and Nagy, Marcell and Borbásné Farkas, Kornélia and Sipos, Zoltán and Fehérvári, Péter and Pecze, László and Földi, Mária and Vincze, Áron and Takács, Tamás and Czakó, László and Szabó-Halász, Adrienn and Boros, Eszter and Hamvas, József and Varga, Márta and Mickevicius, Artautas and Faluhelyi, Nándor and Farkas, Orsolya and Váncsa, Szilárd and Nagy, Rita and Bunduc, Stefania and Hegyi, Péter Jenő and Márta, Katalin and Borka, Katalin and Doros, Attila and Hosszúfalusi, Nóra and Zubek, László and Erőss, Bálint Mihály and Molnár, Zsolt and Párniczky, Andrea and Hegyi, Péter and Szentesi, Andrea Ildikó and Izbéki, Ferenc}, doi = {10.1038/s41598-022-11517-w}, journal-iso = {SCI REP}, journal = {SCIENTIFIC REPORTS}, volume = {12}, unique-id = {32823615}, issn = {2045-2322}, abstract = {Pancreatic necrosis is a consistent prognostic factor in acute pancreatitis (AP). However, the clinical scores currently in use are either too complicated or require data that are unavailable on admission or lack sufficient predictive value. We therefore aimed to develop a tool to aid in necrosis prediction. The XGBoost machine learning algorithm processed data from 2387 patients with AP. The confidence of the model was estimated by a bootstrapping method and interpreted via the 10th and the 90th percentiles of the prediction scores. Shapley Additive exPlanations (SHAP) values were calculated to quantify the contribution of each variable provided. Finally, the model was implemented as an online application using the Streamlit Python-based framework. The XGBoost classifier provided an AUC value of 0.757. Glucose, C-reactive protein, alkaline phosphatase, gender and total white blood cell count have the most impact on prediction based on the SHAP values. The relationship between the size of the training dataset and model performance shows that prediction performance can be improved. This study combines necrosis prediction and artificial intelligence. The predictive potential of this model is comparable to the current clinical scoring systems and has several advantages over them.}, year = {2022}, eissn = {2045-2322}, orcid-numbers = {Molontay, Roland/0000-0002-0666-5279; Borbásné Farkas, Kornélia/0000-0002-5349-6527; Sipos, Zoltán/0000-0001-7845-8116; Vincze, Áron/0000-0003-2217-7686; Czakó, László/0000-0002-6331-0802; Váncsa, Szilárd/0000-0002-9347-8163; Nagy, Rita/0000-0002-2663-4912; Márta, Katalin/0000-0002-2213-4865; Borka, Katalin/0000-0002-8956-0770; Doros, Attila/0000-0002-6496-9895; Hosszúfalusi, Nóra/0000-0002-9469-372X; Zubek, László/0000-0003-0583-3290; Erőss, Bálint Mihály/0000-0003-3658-8427; Hegyi, Péter/0000-0003-0399-7259; Szentesi, Andrea Ildikó/0000-0003-2097-6927; Németh, Balázs/0000-0001-5338-7577; Papp, Mária/0000-0003-3662-4010; Szakács, Zsolt/0000-0002-7035-941X; Izbéki, Ferenc/0000-0001-7767-4319} } @article{MTMT:32582747, title = {Recurrent acute pancreatitis prevention by the elimination of alcohol and cigarette smoking (REAPPEAR): protocol of a randomised controlled trial and a cohort study}, url = {https://m2.mtmt.hu/api/publication/32582747}, author = {Ocskay, Klementina and Juhász, Márk Félix and Borbásné Farkas, Kornélia and Zádori, Noémi and Szakó, Lajos and Szakács, Zsolt and Szentesi, Andrea Ildikó and Erőss, Bálint Mihály and Miklós, Emőke and Zemplényi, Antal Tamás and Birkás, Béla and Csathó, Árpád and Hartung, István and Nagy, Tamás and Czopf, László and Izbéki, Ferenc and Gajdán, László and Papp, Mária and Czakó, László and Illés, Dóra and Marino, Marco V and Mirabella, Antonello and Małecka-Panas, Ewa and Zatorski, Hubert and Susak, Yaroslav and Opalchuk, Kristina and Capurso, Gabriele and Apadula, Laura and Gheorghe, Cristian and Saizu, Ionut Adrian and Petersen, Ole H and de-Madaria, Enrique and Rosendahl, Jonas and Párniczky, Andrea and Hegyi, Péter}, doi = {10.1136/bmjopen-2021-050821}, journal-iso = {BMJ OPEN}, journal = {BMJ OPEN}, volume = {12}, unique-id = {32582747}, issn = {2044-6055}, year = {2022}, eissn = {2044-6055}, orcid-numbers = {Ocskay, Klementina/0000-0001-5848-2506; Borbásné Farkas, Kornélia/0000-0002-5349-6527; Szakács, Zsolt/0000-0002-7035-941X; Szentesi, Andrea Ildikó/0000-0003-2097-6927; Erőss, Bálint Mihály/0000-0003-3658-8427; Zemplényi, Antal Tamás/0000-0002-0177-0264; Birkás, Béla/0000-0002-6380-7093; Nagy, Tamás/0000-0001-5437-1411; Czopf, László/0000-0001-9565-0732; Izbéki, Ferenc/0000-0001-7767-4319; Papp, Mária/0000-0003-3662-4010; Czakó, László/0000-0002-6331-0802; Hegyi, Péter/0000-0003-0399-7259} } @misc{MTMT:32477077, title = {A COVID-19 SÚLYOSSÁGÁT ELŐRE JELZIK AZ ELSŐ ELLÁTÁS SORÁN MÉRT KLINIKAI TÜNETEK ÉS PARAMÉTEREK – EGYCENTRUMOS, RETROSPEKTÍV KLINIKAI VIZSGÁLAT}, url = {https://m2.mtmt.hu/api/publication/32477077}, author = {Németh, Balázs and Inczefi, Orsolya and Iglói, Gábor and Ollé, Georgina and Dani, Kristóf Tamás and Fejes, Imola and Horváth, Ágnes Judit and Illés, Dóra and Greff, Dorottya and Christofi, Alexandros and Szalatnyai, Bálint and Roczkov, Anett and Tajti, Máté and Laczkó, Edit and Riesz, Tamás János and Éberhardt, Gábor and Kiss, Nóra Ágnes and Kiss, Tamás and Visnyovszki, Ádám and Nagy, Nóra and Orosz, László and Farkas, Attila and Sepp, Krisztián and Róka, Richárd László}, unique-id = {32477077}, year = {2021}, orcid-numbers = {Németh, Balázs/0000-0001-5338-7577; Inczefi, Orsolya/0000-0001-7974-1263; Horváth, Ágnes Judit/0000-0003-3964-0729; Sepp, Krisztián/0000-0001-9400-5213} }